The week in health tech, explained in plain English.Get the free newsletter →
November 1, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

AI Finally Changes the Math on Healthcare Fraud

Healthcare fraud, waste, and abuse drains more than $100 billion from the U.S. system every year, and by some estimates several times that, according to HIT Consultant. That number has been stubbornly familiar for decades. What has changed is the detection technology. AI can now scan claims, billing patterns, and provider behavior at a scale and speed that legacy rules-based systems never could, flagging anomalies that human auditors would miss.

The practical shift is from reactive to proactive. Older methods chased fraud after payment through a slow "pay and chase" cycle. Modern AI models can spot suspicious patterns before dollars go out the door, tightening the window that bad actors exploit. That reframes the economics: the cost of catching fraud is falling as the tools mature.

The open question, HIT Consultant argues, is adoption. The technology works. Whether payers, providers, and regulators will invest in it and act on its findings, rather than tolerate losses as a cost of doing business, is now the deciding factor.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.